Hangzhou Jiuyuan Gene

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is a biopharmaceutical company that researches, develops, manufactures, and commercializes biopharmaceutical products and medical devices in Mainland China and internationally. Its product portfolio includes Guyoudao (bone repair material), Jilifen (human granulocyte colony stimulating factor injection), Jijufen (human interleukin-11 injection), Jiouting (palonosetron hydrochloride injection), Jifuwei (fulvestrant injection), Jitansu (fosaprepitant dimeglumine injection), Jixinfen (PEG-G-CSF injection), Jilixin (avatrombopag maleate tablets), Jipailin (low molecular weight heparin sodium injection), and Yinuojia (enoxaparin sodium injection). The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Incorporated in 1993, it is headquartered in Hangzhou, China.